No. As of September 2026, MetLife, Inc. (MET) is classified as NOT HALAL by Maz Vantage: its line of business (Insurance - Life) is excluded under every published Shariah methodology, whatever its balance sheet.
No. As of September 2026, MetLife, Inc. (MET) is classified as NOT HALAL by Maz Vantage: its line of business (Insurance - Life) is excluded under every published Shariah methodology, whatever its balance sheet.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.
MetLife, Inc. (NYSE: MET) is a Financial Services company (Insurance - Life) with a market capitalization of $63.8B. The Maz Rating grades it against the other companies in its sector.
MetLife, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $101.50, MetLife, Inc. trades at 13.1x trailing earnings, 0.8x sales and 2.9x book value, with an EV/EBITDA of 8.5. Over the last twelve months it generated about $82.6B of revenue and $4.9B of net income. It runs a gross margin of 29.2%, an operating margin of 8.4% and a net margin of 6.2%. It shows return on equity of 19.5%, return on invested capital of 1.0% and a free cash flow yield of 23.5%. On the balance sheet: a debt-to-equity ratio of 0.98 and a current ratio of 2.29. Over the past 52 weeks the share price ranged from $67.33 to $106.72, with a beta of 0.77.
MetLife, Inc. pays a dividend yielding 2.32%, with 32% of earnings paid out. Its Maz Dividend Score is 4.83 out of 5, ranked against the other dividend payers in its sector (Safety 4.32, Growth 3.51, Yield 3.48, Consistency 3.85).
33 Wall Street analyst ratings cover the stock: 26 Buy and 7 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
MetLife, Inc. operates as a leading global financial services entity, delivering an extensive array of services encompassing insurance, annuities, employee benefits, and asset management. The company manages its operations through five primary divisions: the U.S., Asia, Latin America, Europe, the Middle East and Africa (EMEA), and MetLife Holdings. Its broad insurance offerings include life, dental, group short-term and long-term disability, individual disability, pet, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans. MetLife also supports employers with administrative services-only (ASO) arrangements. Furthermore, it provides sophisticated financial instruments such as general and separate account contracts, synthetic guaranteed interest contracts, and private floating rate funding agreements. The company facilitates pension risk transfers, offers institutional income annuities, structures settlements, and delivers capital markets investment products. Specialized life insurance products and funding agreements are also available for post-retirement benefits, alongside company, bank, or trust-owned life insurance used to finance non-qualified executive benefit programs. In addition, MetLife offers a variety of annuity options including fixed, indexed-linked, and variable, alongside pension and regular savings products. Its life insurance portfolio features whole life, term life, endowments, universal and variable life, and group life policies. The company also provides longevity reinsurance solutions, credit insurance products, and protection for long-term healthcare services. MetLife, Inc. was founded in 1863 and is headquartered in New York City.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.